Found "AI":  1,093 results
Pfizer to return rights to three Acura products
                    The license termination, which concerns three clinical-stage products using Acura’s Aversion technology, will be effective a year from Thursday, when Pfizer notified the company.“We will evaluate our strategy for these products (being returned) over the coming months, including possible partnering w                
                
                
            HITAP joins with partners to organize a side meeting on Learning from practice: HTA capacity development across Asia
                    Since Universal Health Coverage (UHC) is high on the global health agenda, governments of many low- and middle-income countries (LMICs) have pledged to increase health investments in order to offer universal access to essential health services. Health technology assessment (HTA) has been recognized                
                
                
            A World Without AIDS, Still Worlds Away
                    WASHINGTON — Is the world on the verge of ending the AIDS epidemic and creating an AIDS-free generation, even though a cure and a vaccine are still distant hopes?Yes, roared enthusiasts among the nearly 24,000 participants at the 19th International AIDS Conference here last week. Their hopes are bas                
                
                
            Obama administration says states will join Medicaid expansion
                    (Reuters) – The Obama administration on Monday said it expects that U.S. states will eventually join its planned expansion of the Medicaid healthcare program as they evaluate the benefits of providing health coverage to more low-income people.U.S. Medicaid director Cindy Mann said states will likely                
                
                
            FDA rejects expanded use of Regeneron drug for gout
                    The rejection follows a unanimous vote against the drug’s approval in early May by advisors to the U.S. Food and Drug Administration, with panel members expressing concern that the company had only done a 16-week study.The agency has requested additional clinical data, including chemistry, manufactu                
                
                
            Caesarean sections result in infections for one in ten patients, study finds
                    NHS urged to make reduction of problem a priority as overweight and teenage mothers found to be most likely to sufferOne in 10 women who have a baby by caesarean section go on to develop an infection around their scar, which causes them pain and discomfort and forces some to go back into hospital to                
                
                
            Pulling the plug on drug detention centres in Asia
                    The Lancet“No treatment for the disease of addiction was available there. Once a month or so we marched around for a couple of hours chanting slogans”, Huong Son, who had been detained for 4 years in a so-called drug treatment centre in Ho Chi Minh City, Vietnam, told Human Rights Watch (HRW). Son’s                
                
                
            Designing a decision frame for making health resource allocation decisions: a case study in Thailand
                    The abundance of various innovations in healthcare (pharmaceuticals, medical devices, interventions, individual and community health promotion and disease prevention as well as a social health policy) have been continuously used in the healthcare system, resulting in a higher demand for resources and budgets in disease prevention and healthcare. Th                
                
                
            China detains almost 2,000 in fake drug sweep
                    (Reuters) – Chinese police have detained almost 2,000 people in a nationwide sweep on fake drugs, seizing more than $180 million worth of counterfeit products and destroying some 1,100 production facilities, the public security ministry said on Sunday.The operation, involving around 18,000 police of                
                
                
            U.S. FDA approves generic versions of Merck’s Singulair
                    (Reuters) – The U.S. Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair, the $5 billion-a-year asthma and allergy drug that is Merck & Co Inc’s best-selling product.The drugmakers, whose cheaper versions of Singulair                
                
                
            
        
  10 / Page
        
      
      